46.19.Z - Activity of agents involved in wholesale trade of non-specialized goods
21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations
46.18.Z - Activity of agents involved in wholesale trade of other specified goods
46.45.Z - Wholesale trade of perfumes and cosmetics
46.46.Z - Wholesale trade of pharmaceutical and medical products
47.73.Z - Retail sale of pharmaceutical products
47.74.Z - Retail sale of medical and orthopedic products
70 - Head office activities and management consultancy
73.1 - Advertising
73.20.Z - Market research and public opinion polling
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Profit (loss) on sale | 106,4 | |||
Gross profit (loss) | 2,2 | 2,9 | 2,4 | -17,2 |
EBITDA | 2,1 | 2,8 | 2,8 | 1,5 |
Short time liabilities | 2,5 | 2,4 | 1,7 | -29,4 |
Other operating costs | 10 | |||
Equity capital | 3,9 | 4,7 | 3,7 | -22,5 |
Operating profit (EBIT) | 2,1 | 2,8 | 2,8 | 1 |
Assets | 6,4 | 7,1 | 5,4 | -24,5 |
Net profit (loss) | 1,8 | 2,8 | 1,8 | -37,3 |
Cash | 2,2 | 2,9 | 0,9 | -69,6 |
Liabilities and provisions for liabilities | 2,5 | 2,4 | 1,7 | -28,5 |
Net income from sale | 10,2 | 14,7 | 19,7 | 34,4 |
Working assets | 6,4 | 7,1 | 5,3 | -24,9 |
Other income costs | -89,6 | |||
Depreciation | 0 | 0 | 0 | -∞ |
% | % | % | p.p. | |
Profitability of capital | 45,9 | 60,1 | 48,6 | -11,5 |
Equity capital to total assets | 60,5 | 66,7 | 68,5 | 1,8 |
Gross profit margin | 21,2 | 19,5 | 12 | -7,5 |
EBITDA Margin | 20,3 | 19,1 | 14,4 | -4,7 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 89 | 59 | 31 | -28 |
Current financial liquidity indicator | 2.5940561294555664 | 2.9820408821105957 | 3.130016803741455 | 0,1 |
Net dept to EBITDA | -1.005802869796753 | -1.019529104232788 | -0.3082851767539978 | 0,7 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane